ARCHIVES

ODAC Recommendation for Pertuzumab Signals FDA’s Resolve In Granting Accelerated Approvals

This article is from The Cancer Letter archive.

Vol. 39 No. 35 | September 20, 2013

Download PDF Visit The Full Archive

Related Articles

New CREG Announcements Made By NCI

October 3, 1975

NCI Advisors Approve Plans To Continue Current Research Programs.

July 3, 2008

ESA Risk Mitigation Strategy Requires Training, Patient Consent, Documentation

February 19, 2010

Talking Back: FDA Faces Challenges Over Avastin & Prostate Cancer Prevention

January 21, 2011

Tri-Institutional Stem Cell Initiative Funds Grants.

August 4, 2006

New ACR Mammography Guidelines Suggest Annual Screening For Women Age 40-50

November 12, 1982